Search Results - Brett Hanscom

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women by Deborah Donnell, Fei Gao, James P. Hughes, Brett Hanscom, Lawrence Corey, Myron S. Cohen, Srilatha Edupuganti, Nyaradzo Mgodi, Helen Rees, Jared M. Baeten, Glenda Gray, Linda‐Gail Bekker, Mina Hosseinipour, Sinead Delany‐Moretlwe

    Published in Journal of the International AIDS Society (2023-06-01)
    Get full text
    Article


  2. 2

    Population‐level impact of expanding PrEP coverage by offering long‐acting injectable PrEP to MSM in three high‐resource settings: a model comparison analysis by Sarah E. Stansfield, Jesse Heitner, Kate M. Mitchell, Carla M. Doyle, Rachael M. Milwid, Mia Moore, Deborah J. Donnell, Brett Hanscom, Yiqing Xia, Mathieu Maheu‐Giroux, David van de Vijver, Haoyi Wang, Ruanne Barnabas, Marie‐Claude Boily, Dobromir T. Dimitrov

    Published in Journal of the International AIDS Society (2023-07-01)
    Get full text
    Article


  3. 3

    Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trial by Kostyantyn Dumchev, Xu Guo, Tran Viet Ha, Zubairi Djoerban, Oleksandr Zeziulin, Vivian F. Go, Riza Sarasvita, David S. Metzger, Carl A. Latkin, Scott M. Rose, Estelle Piwowar-Manning, Paul Richardson, Brett Hanscom, Kathryn E. Lancaster, William C. Miller, Irving F. Hoffman

    Published in BMC Infectious Diseases (2023-05-01)
    Get full text
    Article


  4. 4

    Estimated impact of long‐acting injectable PrEP in South Africa: a model comparison analysis by Sarah E. Stansfield, Mia Moore, Lise Jamieson, Gesine Meyer‐Rath, Leigh F. Johnson, David Kaftan, Anna Bershteyn, Jennifer Smith, Valentina Cambiano, Loveleen Bansi‐Matharu, Andrew Phillips, Jesse Heitner, Ruanne V. Barnabas, Brett Hanscom, Deborah J. Donnell, Marie‐Claude Boily, Dobromir Dimitrov

    Published in Journal of the International AIDS Society (2025-07-01)
    Get full text
    Article


  5. 5

    Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial... by David Goodman-Meza, Steven Shoptaw, Brett Hanscom, Laramie R. Smith, Philip Andrew, Irene Kuo, Jordan E. Lake, David Metzger, Ellen A. B. Morrison, Melissa Cummings, Jessica M. Fogel, Paul Richardson, Jayla Harris, Jesse Heitner, Sarah Stansfield, Nabila El-Bassel, for the HPTN 094 Study Team

    Published in Trials (2024-02-01)
    Get full text
    Article


  6. 6

    HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074. by Philip J Palumbo, Yinfeng Zhang, Jessica M Fogel, Xu Guo, William Clarke, Autumn Breaud, Paul Richardson, Estelle Piwowar-Manning, Stephen Hart, Erica L Hamilton, Ngo T K Hoa, Mariya Liulchuk, Latifah Anandari, Tran Viet Ha, Kostyantyn Dumchev, Zubairi Djoerban, Irving Hoffman, Brett Hanscom, William C Miller, Susan H Eshleman

    Published in PLoS ONE (2019-01-01)
    Get full text
    Article


  7. 7

    Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084 by Sinead Delany‐Moretlwe, Brett Hanscom, Xu Guo, Clemensia Nkabiito, Patricia Mandima, Patricia Ntege Nahirya, Juliet Mpendo, Muchaneta Bhondai‐Mhuri, Nyaradzo Mgodi, Rebecca Berhanu, Jennifer Farrior, Estelle Piwowar‐Manning, Susan L. Ford, Craig W. Hendrix, Alex R. Rinehart, James F. Rooney, Adeola Adeyeye, Raphael J. Landovitz, Myron S. Cohen, Mina C. Hosseinipour, Mark A. Marzinke, the HPTN 084 Study Team

    Published in Journal of the International AIDS Society (2025-01-01)
    Get full text
    Article


  8. 8

    Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV by Tariro D. Chawana, Stephen R. Walsh, Lynda Stranix-Chibanda, Zvavahera M. Chirenje, Chenchen Yu, Lily Zhang, Kelly E. Seaton, Jack Heptinstall, Lu Zhang, Carmen A. Paez, Theresa Gamble, Shelly T. Karuna, Philip Andrew, Brett Hanscom, Magdalena E. Sobieszczyk, Srilatha Edupuganti, Cynthia L. Gay, Sharon B. Mannheimer, Christopher B. Hurt, Kathryn E. Stephenson, Laura L. Polakowski, Hans Spiegel, Margaret Yacovone, Stephanie Regenold, Catherine Yen, Jane AG. Baumblatt, Lucio Gama, Dan H. Barouch, Estelle Piwowar-Manning, Richard A. Koup, Georgia D. Tomaras, Ollivier Hyrien, Alison C. Roxby, Yunda Huang, on behalf of the HVTN 127/HPTN 087, HVTN 130/HPTN 089 and HVTN 136/HPTN 092 Study Teams

    Published in BMC Immunology (2025-02-01)
    Get full text
    Article


Search Tools: